Novavax
NVAX
#5852
Rank
NZ$1.83 B
Marketcap
NZ$11.31
Share price
-1.79%
Change (1 day)
-27.65%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2025 (TTM): NZ$0.65 Billion

According to Novavax's latest financial reports the company's current earnings are NZ$1.02 Billion. In 2024 the company made an earning of -NZ$0.27 Billion, an increase over its 2023 earnings that were of -NZ$0.91 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$0.65 B-342.85%
2024 -NZ$0.27 Billion-70.39%
2023 -NZ$0.91 Billion-16.59%
2022 -NZ$1.1 Billion-62.58%
2021 -NZ$2.92 Billion320.54%
2020 -NZ$0.7 Billion234.22%
2019 -NZ$0.21 Billion-30.17%
2018 -NZ$0.3 Billion1.69%
2017 -NZ$0.3 Billion-36.44%
2016 -NZ$0.46 Billion70.4%
2015 -NZ$0.27 Billion89.27%
2014 -NZ$0.15 Billion59.83%
2013 -NZ$89.17 Million81.9%
2012 -NZ$49.02 Million50.33%
2011 -NZ$32.61 Million
2009 -NZ$64.36 Million8.8%
2008 -NZ$59.15 Million18.01%
2007 -NZ$50.13 Million18.33%
2006 -NZ$42.36 Million168.31%
2005 -NZ$15.79 Million-62.51%
2004 -NZ$42.12 Million52.4%
2003 -NZ$27.64 Million-28.21%
2002 -NZ$38.5 Million
2000 -NZ$21.94 Million177%
1999 -NZ$7.92 Million-11.54%
1998 -NZ$8.96 Million10.64%
1997 -NZ$8.1 Million-9.62%
1996 -NZ$8.96 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Agenus
AGEN
NZ$35.56 M-94.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-NZ$0.44 Billion-167.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$0.28 B-55.92%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-NZ$11.4 Million-101.76%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$22.53 B 3,390.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
NZ$20.40 B 3,060.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$28.26 B 4,278.51%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
-NZ$16.3 Million-102.52%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$16.04 B 2,386.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-NZ$0.45 Billion-168.33%๐Ÿ‡บ๐Ÿ‡ธ USA